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Abstract
Introduction. Needle biopsy, including core needle biopsy (CNB) and vacuum-assisted breast biopsy (VABB) with or without radiological support) is the initial
investigative method of choice for the preoperative diagnosis of breast lesions. Ultrasound-guided VABB (US-VABB) has become widely accepted because of its high
accuracy. In this review, the diagnostic performance indices of CNB were compared with US-VABBB techniques.
Method. A literature search proceeded in online databases compiling studies from the last 20 years in the PubMed, EBSCOhost, ScienceDirect, and ProQuest databases.
Eighteen eligible studies compared US-VABB and CNB for diagnostic accuracy. All studies were cohort retrospective. This literature search proceeded according to the
PRISMA.
Results. Eighteen retrospective studies in three categories: comparative studies of US-VABB and CNB and the diagnostic accuracy of US-VABB and CNB. The studies
showed that US-VABB has higher sensitivity and specificity than CNB but lower inadequacy and underestimation rates in the comparative studies group. In addition,
the diagnostic accuracy of US-VABB is higher than CNB when comparing the other two subgroups (sensitivity and specificity: 94.4%-100% vs. 82%-90% and 98%100% vs. 96%-98%, respectively).
Conclusion. US-VABB has higher overall diagnosis accuracy than CNB.
Keywords: breast cancer; breast biopsy; vacuum-assisted breast biopsy; core needle biopsy; ultrasound-guided vacuum-assisted breast biopsy

Introduction
The breast consists of three main parts, lobules (milk-producing glands),
ducts (tubes that carry milk through the nipples for secretion), and
connective tissue (composed of fibrous tissue and fat) surrounding and
providing support to the breast. Breast tumors could be benign or
malignant (cancer). Most breast cancers are found in the excretory ducts
or lobules.1 The average woman's risk of developing breast cancer is
13%, which means that 1 in 8 women will develop breast cancer at some
point in their lives. According to Globocan, the incidence of breast
cancer is 20% of all malignancies. In Indonesia, breast cancer is the most
common cancer, and it is estimated that there are more than 65,000 cases
and about 22,000 deaths due to breast cancer. This cancer is a significant
burden in Indonesia, with more than 50% of breast cancer patients in
Indonesia in an advanced stage.2
Early diagnosis of breast cancer is still necessary. Various methods have
yielded satisfactory results, such as mammography, fine-needle
aspiration biopsy (FNAB), and core needle biopsy (CNB).3 CNB is the
most commonly used diagnostic method for nonpalpable and palpable
lesions worldwide for its high accuracy, cost-effectiveness, low
complication rate, and convenience. Despite these advantages, it is not
an anti-failure method because of the high rate of false-negative findings
and misclassification, which were inevitable because the procedure
involves sampling merely a small part of the target rather than the entire
lesion.4,5
Recent advances in ultrasound diagnostics allowed early detection of
nonpalpable malignant lesions measuring less than 1 cm, contributing to
increased breast cancer survival rates. Vacuum-assisted breast biopsy
(VABB), also known as mammotomy biopsy, has been accepted as a
safe and effective procedure. Such a procedure maximizes diagnostic
accuracy by performing excisional biopsies for most breast diseases
while minimizing post-procedural scarring and complications. In
addition, the method provides clinical benefits as it can proceed under
the guidance of sonography, mammography, or magnetic resonance

imaging.4 Ultrasound-guided procedures remain discussed to replace
surgical biopsy for nodular lesions and even surgical excision of benign
lesions. This review aimed to compare the diagnostic accuracy between
ultrasound-guided vacuum-assisted breast biopsy (US-VABB) and
CNB, as well as their applicability and complication rate.
Method
A literature search proceeded on the PubMed, EBSCOhost,
ScienceDirect, and ProQuest databases. Keywords used were following
the Medical Subject Headings (MeSH) terms: breast cancer or breast
calcification and ultrasound and vacuum assisted biopsy or
mammotome or EnCor and large needle core biopsy or needle core
biopsy. The reference of the relevant articles was also screened to
identify eligibility. The inclusion was prospective, and retrospective
studies focused on the diagnostic accuracy of US-VABB and CNB
published between January 2001 to December 2021; patients with
ductal carcinoma in situ (DCIS) were diagnosed with USG–guided
VAB or core needle stereotactic. These articles were screened based on
title and abstract and then appraised for validity, importance, and
applicability using specific tools: the cohort, case series, and case report
were each appraised using Joanna Briggs Institute, Faculty of Health and
Medical Sciences, checklist for cohort, case series, and case reports
studies (critical appraisal tools). The literature search proceeded
according to the PRISMA (Figure 1)
Results
Of one hundred seventy identified articles in the four databases, 156
were screened, and eighteen met the criteria. All were retrospective
cohorts comprised of three categories: comparative studies of USVABB and CNB (4 articles), studies related to the diagnostic accuracy
of US-VABB (9 articles), and studies related to the diagnostic accuracy
of CNB (5 articles).
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Figure 1. The literature searching process and results using Prisma flow 2020.
Table 1. Characteristics of Comparative Studies
Author
Study Design
Diagnosis
(Year)
Ciatto
(2007)6

Retrospective
Study

DCIS

NA

1391
(US-VABB)
2646 (CNB)

Biopsy
Methods
USVABB
CNB

Lacambra
(2011)7

Retrospective
Study

DCIS

NA

285
(US-VABB)
179 (CNB)

USVABB
CNB

11
14

Ultrasound

Histopathological
Diagnosis

Suh
(2012)8

Retrospective
Study

DCIS

NA

56 (US-VABB)
138 (CNB)

USVABB
CNB

11
14

Ultrasound

Histopathological
Diagnosis

Age

Samples

Biopsy
Needle

Guidance

Reference Standard

11
14

Ultrasound

Histopathological
Diagnosis

Retrospective
Study

DCIS

NA

Complication

Inadequacy Rate
US-VABB = 0.29%
CNB = 0.72%
Sensitivity
US-VABB = 96%
CNB = 99%
Specificity
US-VABB= 100%
CNB = 100%

US11
Histopathological
VABB
Ultrasound
14
Diagnosis
CNB
Note: DCIS: ductal carcinoma in situ; NA: not available; US-VABB: ultrasound guided vacuum assisted breast biopsy; CNB: core needle biopsy
Ye (2013)9

Outcome

54 (US-VABB)
98 (CNB)

NA

NA

DCIS
US-VABB = 16.1%
CNB = 47.8%

No complications for
both device

DCIS
US-VABB = 16.6%
CNB = 45.9%

NA

Table 2. Characteristics of ultrasound guided VAB Studies
Author (Year)
Hung (2001)14

Study Design
Retrospective Study

Diagnosis
DCIS
DCIS

Age

Samples

Biopsy
Needle Size

NA

49

11

30-77

73

11

Reference Standard
Histopathological
Diagnosis
Histopathological
Diagnosis
Histopathological
Diagnosis
Histopathological
Diagnosis

Guidance

Sensitivity

Specificity

Ultrasound

100%

100%

Ultrasound

95%

100%

Ultrasound

100%

99%

Ultrasound

97%

100%

Meloni (2001)15

Retrospective Study

Bonifacino
(2005)16

Retrospective Study

DCIS

40-50

146

11

Vag (2007)17

Retrospective Study

DCIS

NA

65

10

Cassano (2007)18

Retrospective Study

DCIS

NA

266

11

Histopathological
Diagnosis

Ultrasound

97%

100%

Shin (2008)19

Retrospective Study

DCIS

NA

123

8

Histopathological
Diagnosis

Ultrasound

100%

100%

Abbate (2009)11

Retrospective Study

DCIS

NA

138

11

Histopathological
Diagnosis

Ultrasound

94.4%

100%

Pan (2014)10

Retrospective study

DCIS

16-73

5232

8

Histopathological
Diagnosis

Ultrasound

100%,
diagnostic
accuracy 100%

NA

Nicosia (2021)20

Retrospective Study

NA

168

13 and 10

Histopathological
Diagnosis

Ultrasound

97.5%

98%

DCIS

Note: DCIS: ductal carcinoma in situ; NA: not available; VAB: vacuum assisted biopsy
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Table 3. Characteristics of CNB Studies
Author (Year)

Study Design

Diagnosis

Age

Samples

Biopsy
Needle Size

White (2001)21

Retrospective Study

DCIS

NA

802

14

Verkooijen
(2002)22

Retrospective Study

DCIS

NA

1029

14

Leifland (2003)13

Retrospective Study

DCIS

NA

448

14

Kyung-Han
(2003)23

Retrospective Study

DCIS

NA

271

14

Huang (2011)12

Retrospective Study

DCIS

NA

218

14

Reference Standard
Histopathological
Diagnosis
Histopathological
Diagnosis
Histopathological
Diagnosis
Histopathological
Diagnosis
Histopathological
Diagnosis

Guidance

Sensitivity

Specificity

Stereotactic

89%

96%

Stereotactic

97%

99%

Stereotactic

90%

98%

Stereotactic

82%

NA

Stereotactic

Diagnostic
Accuracy 84%

NA

Note: DCIS: ductal carcinoma in situ; NA: not available; CNB: core needle biopsy

Comparison of diagnostic accuracy between US-VABB and CNB
Four retrospective studies comparing the diagnostic accuracy of USVABB with CNB had different effect sizes.6-9 Ciatto (2007) compared
the inadequacy rate of the two biopsy techniques. The sample
inadequacy rate has defined the lack of the number of cells identified to
reach a diagnostic conclusion.6 In this case, insufficient samples may be
caused by several factors, including tumor characteristics, method of
guiding, preparation or biopsy techniques, and skills. In the Ciatto study,
the rate of inadequate specimens was lower in US-VABB than in CNB,
indicating a lower likelihood of false-negative results.6 In the study by
Lacambra (2012), the accuracy of diagnosis is determined by sensitivity
and specificity. The results showed that US-VABB has better sensitivity
and specificity than CNB.7 In the studies by Suh (2012) and Ye (2013),
both of which used the underestimation rate of ductal carcinoma in situ
(DCIS), US-VABB was found to perform better than CNB.8,9 Almost
all studies reported no complications in their results; only the study by
Suh (2012) stated that there were no complications, such as bruises or
bleeding with either VAB (47.8%) or CNB (16.1%).8
US-VABB diagnostic accuracy in breast cancer
Nine studies reported on the diagnostic accuracy of US-VABB
compared with histopathologic diagnostic tests. Five studies (55.5%)
used 11G biopsy needles, two studies (22.2%) used 8G, one study
(11.1%) used 10G, and the other used 10 and 13G (11.1%). Eight studies
(88.9%) reported US-VABB sensitivity ranging from 94.4% to 100%
and specificity ranging from 98% to 100%. The study by Pan (2014) did
not report study specificity but reported a sensitivity of 100% and overall
diagnostic accuracy of 100% in a large cohort (n = 5232).10 Most studies
did not report the complications proportion associated with this
procedure; however, Abbate (2009) reported a mild complication rate of
16.1%, with the majority of complications being hematoma, venous
bleeding, clip misplacement, and procedure interruption. No significant
complications were reported in any of the studies.11
CNB diagnostic accuracy in breast cancer
Five studies reported the diagnostic accuracy of CNB, which was also
compared with histopathological diagnosis. All studies used 14G biopsy
needles. Four studies (80%) reported CNB sensitivity in the range of
82to 90%, and three (60%) reported CNB specificity in the range of 96
to 99%. The study by Huang (2011) reported an overall diagnostic
accuracy of CNB of 84%.12 Similar to the US-VABB study, most
studies did not report the percentage of complications of the procedure.
In the study conducted by Leifland (2003), hematomas were reported in
2 of 488 (0.4%) procedures.13 Huang (2011) did not mention the
incidence of complications but noted that ecchymosis, hematoma, and
pain sensations could not be avoided. However, their series showed no
significant complications such as uncontrolled bleeding, severe
postprocedural inflammation, abscess formation, or skin retraction.12

Discussion
Open surgical biopsy remains the gold standard for determining the
pathologic features of breast calcification. Nevertheless, percutaneous
breast biopsy (CNB) and VABB have emerged as reliable alternatives
to open surgical biopsy because of their relatively high accuracy, cost
savings, shorter recovery time, and overall better cosmetic outcome.
Currently, both CNB and VABB have gained precision and are used
more frequently than open biopsy.11
Consistent with the two study subcategories below, the diagnostic
accuracy of US-VABB was higher than that of CNB (82%-90%
sensitivity; specificity 96%-99%) in the single-method studies
(sensitivity 94.4%-100%; specificity 98%-100%). In addition, a study
by Pan (2014) found that the diagnostic accuracy of US-VABB reached
100%, while Huang (2011) reported that the diagnostic accuracy of
CNB was 84%.10,12 Regarding complications, although most studies did
not report their frequency, the studies that reported both methods had
relatively low complication rates, with no significant complications
reported in all studies.
Previous reports have highlighted the advantages of US-VABB biopsy
compared with other methods, such as accuracy, simplicity, and fewer
complications. The advantages of US-VABB are precise positioning
and accurate puncture of the lesion, especially in deep and small tumors
that are not clinically accessible, ensuring sufficient tissue samples for
disease investigation and immunohistochemical detection.4,24 This also
results in a lower rate of inadequate samples at US-VABB compared
with CNB in the study by Ciatto (2007). A sufficient specimen comprise
of tissue or cells in the sample provides adequate pathologic information
to initiate treatment and improve overall patient outcomes.6
In addition, the small puncture hole and cosmetic effect were
satisfactory, with lesions approximately 3 to 5 mm in diameter, without
sutures, and with minimal scarring. Multiple lesions of the same breast
can be punctured through a single puncture hole. This procedure avoids
incisions in the skin, subcutaneous tissue, and normal glands, so tissue
damage is minimal and rapid recovery.25 The choice of biopsy needle
sizes is relatively wider for US-VABB than for CNB (8-11G versus
14G). Nevertheless, the underestimation rate of lesions is much lower,
and diagnostic accuracy is higher with similar complications. In patients
with deep breast masses and obesity, using US-VABB is more
advantageous because larger specimens and potentially inadequate
specimens can be obtained, resulting in better diagnostic accuracy.26 The
larger diameter of the specimen makes it easier for the pathologist to
identify prognostic indicators. This is especially important in patients
with locally advanced breast cancer, as these patients often have altered
or changed molecular information after neoadjuvant therapy.27,28 At the
same time, US-VABB can diagnose and treat tumors simultaneously
and has similar characteristics to minimally invasive and aesthetic
procedures.
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The findings in this review are the advantages and disadvantages of USVABB over CNB regarding diagnostic accuracy and insufficient
sample reduction. However, US-VABB is reported to have a higher cost
burden than conventional CNB. For example, in the study by Mafarjeh
et al., the cost of VAB ranged from 2.2 to 12.5 times that of CNB.29 In
Indonesia, US-VABB is not widely used despite the higher diagnostic
accuracy of the cost of misdiagnosis and underestimation of breast
cancer compared to CNB. Our study had several limitations. First,
because this was a retrospective study, some selection bias for using
biopsy devices could not be avoided. Therefore, we compared the DCIS
underestimation between two biopsy device groups by lesion type to
overcome possible selection bias. Second, the high percentage of mass
lesions in our study population does not reflect the pattern of previous
literature (we compared the DCIS underestimation rates of the two
groups according to the lesion type to minimize the effects of lesion type
on the results. Another possible limitation can be the small number of
mass lesions with VAB to generalize our results. Finally, data analysis
was performed only for the DCIS underestimation rate, not for other
outcomes, such as the rebiopsy or false-negative rates.

6.

7.

8.

9.

10.

11.

Conclusions
Estrogen is not statistically associated with estrogen receptors in
premenopausal breast cancer patients, thus illustrating that the prognosis
of breast cancer patients is not related to the estrogen produced by the
body. Therefore, based on these results, modifying estrogen to get a
better breast cancer prognosis is not a solution.
The risk of breast cancer increases with increasing age. The correlation
between age and estrogen receptors does not show statistical
significance, but there is a clinical meaning. The younger the period, the
lower the estrogen receptor. Therefore, it can be applied in daily health
practice for premenopausal breast cancer patients to predict treatment
options and prognosis. Meanwhile, the estradiol in this study showed
normal premenopausal estradiol in breast cancer patients.
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